These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38097652)

  • 1. Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors.
    Hsu HC; Li D; Zhan W; Ye J; Liu YJ; Leung A; Qin J; Crespo B; Gamo FJ; Zhang H; Cui L; Roth A; Kirkman LA; Li H; Lin G
    Nat Commun; 2023 Dec; 14(1):8302. PubMed ID: 38097652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of Asparagine Ethylenediamines as Anti-malarial
    Zhan W; Visone J; Ouellette T; Harris JC; Wang R; Zhang H; Singh PK; Ginn J; Sukenick G; Wong TT; Okoro JI; Scales RM; Tumwebaze PK; Rosenthal PJ; Kafsack BFC; Cooper RA; Meinke PT; Kirkman LA; Lin G
    J Med Chem; 2019 Jul; 62(13):6137-6145. PubMed ID: 31177777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance.
    Kirkman LA; Zhan W; Visone J; Dziedziech A; Singh PK; Fan H; Tong X; Bruzual I; Hara R; Kawasaki M; Imaeda T; Okamoto R; Sato K; Michino M; Alvaro EF; Guiang LF; Sanz L; Mota DJ; Govindasamy K; Wang R; Ling Y; Tumwebaze PK; Sukenick G; Shi L; Vendome J; Bhanot P; Rosenthal PJ; Aso K; Foley MA; Cooper RA; Kafsack B; Doggett JS; Nathan CF; Lin G
    Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6863-E6870. PubMed ID: 29967165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice.
    Zhan W; Zhang H; Ginn J; Leung A; Liu YJ; Michino M; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Yukawa T; Chelebieva S; Tumwebaze PK; Lafuente-Monasterio MJ; Martinez-Martinez MS; Vendome J; Beuming T; Sato K; Aso K; Rosenthal PJ; Cooper RA; Meinke PT; Nathan CF; Kirkman LA; Lin G
    Angew Chem Int Ed Engl; 2021 Apr; 60(17):9279-9283. PubMed ID: 33433953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.
    Stokes BH; Yoo E; Murithi JM; Luth MR; Afanasyev P; da Fonseca PCA; Winzeler EA; Ng CL; Bogyo M; Fidock DA
    PLoS Pathog; 2019 Jun; 15(6):e1007722. PubMed ID: 31170268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of proteasome inhibitors with oral efficacy in vivo against
    Xie SC; Metcalfe RD; Mizutani H; Puhalovich T; Hanssen E; Morton CJ; Du Y; Dogovski C; Huang SC; Ciavarri J; Hales P; Griffin RJ; Cohen LH; Chuang BC; Wittlin S; Deni I; Yeo T; Ward KE; Barry DC; Liu B; Gillett DL; Crespo-Fernandez BF; Ottilie S; Mittal N; Churchyard A; Ferguson D; Aguiar ACC; Guido RVC; Baum J; Hanson KK; Winzeler EA; Gamo FJ; Fidock DA; Baud D; Parker MW; Brand S; Dick LR; Griffin MDW; Gould AE; Tilley L
    Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34548400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors.
    Garg S; Kreutzfeld O; Chelebieva S; Tumwebaze PK; Byaruhanga O; Okitwi M; Orena S; Katairo T; Nsobya SL; Conrad MD; Aydemir O; Legac J; Gould AE; Bayles BR; Bailey JA; Duffey M; Lin G; Kirkman LA; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0081722. PubMed ID: 36094216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.
    Deni I; Stokes BH; Ward KE; Fairhurst KJ; Pasaje CFA; Yeo T; Akbar S; Park H; Muir R; Bick DS; Zhan W; Zhang H; Liu YJ; Ng CL; Kirkman LA; Almaliti J; Gould AE; Duffey M; O'Donoghue AJ; Uhlemann AC; Niles JC; da Fonseca PCA; Gerwick WH; Lin G; Bogyo M; Fidock DA
    Cell Chem Biol; 2023 May; 30(5):470-485.e6. PubMed ID: 36963402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure- and function-based design of Plasmodium-selective proteasome inhibitors.
    Li H; O'Donoghue AJ; van der Linden WA; Xie SC; Yoo E; Foe IT; Tilley L; Craik CS; da Fonseca PC; Bogyo M
    Nature; 2016 Feb; 530(7589):233-6. PubMed ID: 26863983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemogenomic Profiling of a Plasmodium falciparum Transposon Mutant Library Reveals Shared Effects of Dihydroartemisinin and Bortezomib on Lipid Metabolism and Exported Proteins.
    Pires CV; Oberstaller J; Wang C; Casandra D; Zhang M; Chawla J; Adapa SR; Otto TD; Ferdig MT; Rayner JC; Jiang RHY; Adams JH
    Microbiol Spectr; 2023 Jun; 11(3):e0501422. PubMed ID: 37067430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors.
    Zhang H; Ginn J; Zhan W; Liu YJ; Leung A; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Yukawa T; Michino M; Vendome J; Beuming T; Sato K; Aso K; Meinke PT; Nathan CF; Kirkman LA; Lin G
    J Med Chem; 2022 Jul; 65(13):9350-9375. PubMed ID: 35727231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in
    Bennett JM; Ward KE; Muir RK; Kabeche S; Yoo E; Yeo T; Lam G; Zhang H; Almaliti J; Berger G; Faucher FF; Lin G; Gerwick WH; Yeh E; Fidock DA; Bogyo M
    ACS Infect Dis; 2023 Oct; 9(10):2036-2047. PubMed ID: 37712594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria.
    Li H; Bogyo M; da Fonseca PC
    FEBS J; 2016 Dec; 283(23):4238-4243. PubMed ID: 27286897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Activity Relationship Studies of Antimalarial
    Zhang H; Ginn J; Zhan W; Leung A; Liu YJ; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Michino M; Yukawa T; Chelebieva S; Tumwebaze PK; Vendome J; Beuming T; Sato K; Aso K; Rosenthal PJ; Cooper RA; Liverton N; Foley M; Meinke PT; Nathan CF; Kirkman LA; Lin G
    J Med Chem; 2023 Jan; 66(2):1484-1508. PubMed ID: 36630286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria.
    Lawong A; Gahalawat S; Ray S; Ho N; Han Y; Ward KE; Deng X; Chen Z; Kumar A; Xing C; Hosangadi V; Fairhurst KJ; Tashiro K; Liszczak G; Shackleford DM; Katneni K; Chen G; Saunders J; Crighton E; Casas A; Robinson JJ; Imlay LS; Zhang X; Lemoff A; Zhao Z; Angulo-Barturen I; Jiménez-Díaz MB; Wittlin S; Campbell SF; Fidock DA; Laleu B; Charman SA; Ready JM; Phillips MA
    Cell Chem Biol; 2024 Aug; 31(8):1503-1517.e19. PubMed ID: 39084225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemisinin Action and Resistance in Plasmodium falciparum.
    Tilley L; Straimer J; Gnädig NF; Ralph SA; Fidock DA
    Trends Parasitol; 2016 Sep; 32(9):682-696. PubMed ID: 27289273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution cryo-EM proteasome structures in drug development.
    Morris EP; da Fonseca PCA
    Acta Crystallogr D Struct Biol; 2017 Jun; 73(Pt 6):522-533. PubMed ID: 28580914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
    Siddiqui FA; Boonhok R; Cabrera M; Mbenda HGN; Wang M; Min H; Liang X; Qin J; Zhu X; Miao J; Cao Y; Cui L
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.